ArticlePloS one2024

C-reactive protein-to-lymphocyte ratio is a novel biomarker for predicting the long-term efficacy of ustekinumab treatment in ulcerative colitis.

Ryoji Koshiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.